Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 1
1962 1
1964 1
1965 1
1966 2
1967 2
1968 2
1969 4
1972 1
1973 1
1974 2
1975 1
1976 1
1977 2
1979 2
1980 3
1982 1
1983 2
1986 3
1987 1
1988 4
1989 8
1990 6
1991 15
1992 11
1993 17
1994 9
1995 10
1996 6
1997 3
1998 1
1999 2
2000 2
2001 5
2002 4
2003 7
2004 1
2005 3
2006 2
2007 4
2008 4
2009 2
2010 9
2011 2
2012 4
2013 5
2014 3
2015 4
2016 5
2017 7
2018 6
2019 4
2020 7
2021 4
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Results by year

Filters applied: . Clear all
Page 1
National Athletic Trainers' Association Position Statement: Evaluation, Management, and Outcomes of and Return-to- Play Criteria for Overhead Athletes With Superior Labral Anterior-Posterior Injuries.
Michener LA, Abrams JS, Bliven KCH, Falsone S, Laudner KG, McFarland EG, Tibone JE, Thigpen CA, Uhl TL. Michener LA, et al. Among authors: abrams js. J Athl Train. 2018 Mar;53(3):209-229. doi: 10.4085/1062-6050-59-16. J Athl Train. 2018. PMID: 29624450 Free PMC article.
Inflammatory breast issue.
Coleman CN, Wallner PE, Abrams JS. Coleman CN, et al. Among authors: abrams js. J Natl Cancer Inst. 2003 Aug 20;95(16):1182-3. doi: 10.1093/jnci/djg027. J Natl Cancer Inst. 2003. PMID: 12928334 Review. No abstract available.
Strengthening accrual to cancer clinical trials.
Trimble EL, Denicoff AM, Abrams JS. Trimble EL, et al. Among authors: abrams js. Gynecol Oncol. 2010 Mar;116(3):291-2. doi: 10.1016/j.ygyno.2010.01.015. Gynecol Oncol. 2010. PMID: 20152512 No abstract available.
High-dose chemotherapy for breast cancer.
Gradishar WJ, Tallman MS, Abrams JS. Gradishar WJ, et al. Among authors: abrams js. Ann Intern Med. 1996 Oct 1;125(7):599-604. doi: 10.7326/0003-4819-125-7-199610010-00010. Ann Intern Med. 1996. PMID: 8815759 Review.
New chemotherapeutic agents for breast cancer.
Abrams JS, Moore TD, Friedman M. Abrams JS, et al. Cancer. 1994 Aug 1;74(3 Suppl):1164-76. doi: 10.1002/1097-0142(19940801)74:3+<1164::aid-cncr2820741528>3.0.co;2-k. Cancer. 1994. PMID: 7913662 Review.
Bevacizumab in ovarian cancer.
Korn EL, Freidlin B, Abrams JS. Korn EL, et al. Among authors: abrams js. N Engl J Med. 2012 Mar 29;366(13):1256; author reply 1257-8. doi: 10.1056/NEJMc1201044. N Engl J Med. 2012. PMID: 22455428 No abstract available.
217 results